Amel Chaabane
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Renal Transplantation Outcomes and Treatments 10
-
- Pharmacovigilance and Adverse Drug Reactions 9
- Co-authors
- Karim AouamNadia Ben FredjNaceur A. BoughattasM. ChakrounEmna KerkeniHichem BelhadjaliKamel MonastiriM. Hammouda
- Journals
- British Journal of Clinical Pharmacology (6 papers)The Pharmacogenomics Journal (5 papers)Diabetes & Metabolism (4 papers)The Journal of Clinical Pharmacology (4 papers)Contact Dermatitis (3 papers)
- Partner nations
- TunisiaFranceNetherlands
In The Last Decade
Amel Chaabane
65 papers receiving 493 citations
Peers
Comparison fields: 5 of 78
- Transplantation 81
- Pharmacology 256
- Toxicology 44
- Pharmacology 77
- Dermatology 63
Countries citing papers authored by Amel Chaabane
This map shows the geographic impact of Amel Chaabane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amel Chaabane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amel Chaabane more than expected).
Fields of papers citing papers by Amel Chaabane
This network shows the impact of papers produced by Amel Chaabane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amel Chaabane. The network helps show where Amel Chaabane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amel Chaabane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 6 | |
| 14 | Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data. | 2016 | 8 |
| 15 | 2015 | 2 | |
| 16 | 2015 | 3 | |
| 17 | 2010 | 8 | |
| 18 | 2009 | 20 | |
| 19 | 2009 | 35 | |
| 20 | 2009 | 1 |
About Amel Chaabane
Amel Chaabane is a scholar working on Transplantation, Toxicology, Pharmacology, Dermatology and Pharmacology, having authored 72 papers that have together received 504 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (34 papers), Contact Dermatitis and Allergies (10 papers), Renal Transplantation Outcomes and Treatments (10 papers), Pharmacological Effects and Toxicity Studies (10 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers), Urticaria and Related Conditions (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Transplantation (81 citations), Pharmacology (256 citations), Toxicology (44 citations), Pharmacology (77 citations) and Dermatology (63 citations). Amel Chaabane has collaborated with scholars based in Tunisia, France and Netherlands. Frequent co-authors include Karim Aouam, Nadia Ben Fredj, Naceur A. Boughattas, Naceur A. Boughattas, M. Chakroun, Emna Kerkeni, Hichem Belhadjali, Kamel Monastiri, M. Hammouda and M. Youssef. Their work appears in journals such as British Journal of Clinical Pharmacology, The Pharmacogenomics Journal, Diabetes & Metabolism, The Journal of Clinical Pharmacology and Contact Dermatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.